1. Atsumi T Yamamoto K Takeuchi T Yamanaka H Ishiguro N Tanaka Y Baseline parameters identified in early, methotrexate-naive rheumatoid arthritis patients with better outcomes with certolizumab pegol+methotrexate compared to placebo+methotrexate: Post-hoc analyses of c-opera, a randomized, controlled, phase 3 study Annals of the Rheumatic Diseases.Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2015 Rome Italy. 10 - 13 June 2015 2015 716 7
2. Atsumi T Yamamoto K Takeuchi T Yamanaka H Ishiguro N Tanaka Y Clinical benefit of 1-year certolizumab pegol treatment in MTX-naïve, early rheumatoid arthritis patients is maintained after discontinuation up to 1 year Arthritis and Rheumatology.Conference: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2015 San Francisco, CA United States. 6 - 11 November 2015 2015
3. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression;Atsumi;Annals of the Rheumatic Diseases,2016
4. Atsumi T Yamamoto K Takeuchi T Yamanaka H Ishiguro N Tanaka Y The first early rheumatoid arthritis, certolizumab pegol, multicenter, double-blind, randomized, parallel-group study: C-Opera, in patients fulfilling the 2010 ACR/EULAR classification criteria, demonstrates inhibition of joint damage progression Annals of the Rheumatic Diseases.Conference: Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2014 Paris France. 11 - 14 June 2014 2014
5. Atsumi T Yamamoto K Takeuchi T Yamanaka H Ishiguro N Tanaka Y The first, multicenter, double-blind, randomized, parallel-group study of certolizumab pegol in early rheumatoid arthritis demonstrates inhibition of joint damage progression Arthritis and Rheumatology.Conference: 2014 ACR/ARHP Annual Meeting Boston, MA United States. 14 - 19 November 2014 2014 S1078 9